USANA Health Sciences Revenue, Profits - USNA Annual Income Statement

Add to My Stocks
$124.1 $0.15 (0.12%) USNA stock closing price Sep 18, 2018 (Closing)

Fundamental analysis of USNA stock involves analyzing its financial statements, apart from checking the USANA Health Sciences stock price. The key financial statements of a company are the income statement, the balance sheet and the cash flow statement. The income statement is generated for a specific period of time, typically a year or a quarter. The revenue increase to $1.05B for 2017 impacts the USNA stock. Investors typically check year over year or quarter over quarter revenue growth. Along with USANA Health Sciences assets and USANA Health Sciences free cash flow, USANA Health Sciences profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $62.53M and the 2017 revenue is $1.05B.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
USANA Health Sciences Revenues or Net Sales
1.05B1.01B918.49M790.47M718.17M648.72M581.93M517.64M436.94M429.01M
Cost Of Goods Sold (COGS)179.4M180.19M159.68M140.79M127.43M115.8M101.69M95.48M89.8M88.87M
USANA Health Sciences Gross Profit
867.86M825.89M758.81M649.67M590.74M532.92M480.24M422.16M347.13M340.13M
Research & Development Expense----------
Selling General & Admin Expense735.35M687.27M617.15M533.57M474.02M434.74M402.99M353.94M296.34M292.13M
Income Before Depreciation Depletion Amortization132.5M138.62M141.66M116.1M116.71M98.17M77.25M68.21M50.79M47.99M
Depreciation Depletion Amortization----------
Non Operating Income2.18M---0.32M-0.13M-----0.88M
Interest Expense----------
USANA Health Sciences Pretax Income
134.64M138.55M142.58M115.65M116.58M98.42M77.47M68.86M50.97M46.32M
Provision for Income Taxes72.1M38.51M47.91M39.01M37.55M31.99M26.72M23.21M17.42M16.37M
MinorityInterest----------
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations62.53M100.04M94.67M76.63M79.02M66.43M50.75M45.65M33.55M29.94M
Extraordinary Items & Discontinued Operations----------
USANA Health Sciences Profit/ Loss (Net Income)
62.53M100.04M94.67M76.63M79.02M66.43M50.75M45.65M33.55M29.94M
Average Shares used to compute Diluted EPS24.71M25.05M26.35M27.38M28.41M29.85M31.15M31.88M30.86M32.33M
Average Shares used to compute Basic EPS24.71M25.05M26.35M27.38M28.41M29.85M31.15M31.88M30.86M32.33M
Income Before Nonrecurring Items100.27M100.04M94.67M76.64M79.02M66.43M50.75M45.65M33.56M34.17M
Income from Nonrecurring Items-37.74M---------4.22M
USANA Health Sciences Earnings Per Share Basic Net
2.533.993.592.802.782.231.631.431.090.93
USANA Health Sciences Earnings Per Share Diluted Net
2.533.993.592.802.782.231.631.431.090.93
EPS Diluted Before Nonrecurring Items4.063.993.592.802.782.231.631.431.091.06
Preferred Dividends Acc Pd----------
Dividends Common----------
Dividend Per Share Common0.000.000.000.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing USANA Health Sciences stock analysis are:

  • Revenue: The money received by selling of goods or services comes under this line item. A YoY growth - See: USANA Health Sciences revenue chart implies that the company is growing. It has been the case with USANA Health Sciences. One must look at stocks with increasing revenues, and stay away from stocks whose revenues or sales are declining.
  • Bottom line: Most businesses like USANA Health Sciences try to grow their profits by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.

The income statement is also called the profit and loss statement. Apart from the USNA income statement, one can check the USANA Health Sciences historical stock prices to check how the price has moved with time.

USANA Health Sciences Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
37.84
PS Ratio (price sales ratio)
2.73
Operating Margin
17
Net Profit Margin
11.2
Dividend Yield
0%